AQR Arbitrage’s Precigen PGEN Stock Holding History

AQR Arbitrage’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,855	Closed	-$51K	–	1246
2022 Q3	$51K	Hold	23,855	–	–	﹤0.01%	858
2022 Q2	$32K	Hold	23,855	–	–	﹤0.01%	992
2022 Q1	$50K	Hold	23,855	–	–	﹤0.01%	912
2021 Q4	$89K	Hold	23,855	–	–	﹤0.01%	1202
2021 Q3	$119K	Hold	23,855	–	–	﹤0.01%	789
2021 Q2	$156K	Hold	23,855	–	–	﹤0.01%	799
2021 Q1	$164K	Sell	23,855 -23,086	-49%	-$195K	0.01%	792
2020 Q4	$479K	Hold	46,941	–	–	0.02%	680
2020 Q3	$164K	Sell	46,941 -60,448	-56%	-$287K	0.01%	518
2020 Q2	$536K	Sell	107,389 -88,445	-45%	-$301K	0.02%	353
2020 Q1	$666K	Sell	195,834 -54,849	-22%	-$237K	0.02%	309
2019 Q4	$1.37M	Sell	250,683 -14,746	-6%	-$83K	0.02%	283
2019 Q3	$1.52M	Sell	265,429 -452	-0.2%	-$3.07K	0.02%	258
2019 Q2	$2.04M	Buy	265,881 +53,326	+25%	+$287K	0.02%	260
2019 Q1	$1.12M	Buy	212,555 +67,796	+47%	+$470K	0.01%	256
2018 Q4	$947K	Buy	+144,759	New	+$1.62M	0.01%	279

Other funds holding PGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Arbitrage's PGEN Position: Q4 2022 in Review

AQR Arbitrage sold out of Precigen (PGEN) in Q4 2022, closing a stake of 23,855 shares — an estimated $51K sold.

AQR Arbitrage first reported a position in PGEN in Q4 2018 and held it in 16 quarters. The position peaked at $2.04M in Q2 2019. 161 funds tracked by Wall St. Rank hold PGEN as of Q4 2022.

AQR Arbitrage reported no remaining Precigen position as of Q4 2022 after selling out during the quarter.
AQR Arbitrage sold 23,855 Precigen shares in Q4 2022, an estimated $51K.
AQR Arbitrage first reported a position in Precigen in Q4 2018 and held it in 16 quarters.
AQR Arbitrage's Precigen position peaked at $2.04M in Q2 2019.
161 funds tracked by Wall St. Rank held Precigen as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.